Dopamine Transporter Neuroimaging as an Enrichment Biomarker in Early Parkinson's Disease Clinical Trials: A Disease Progression Modeling Analysis

Publisher： John Wiley & Sons Inc

E-ISSN： 1752-8062|11|1|63-70

ISSN： 1752-8054

Source： CLINICAL AND TRANSLATIONAL SCIENCE (ELECTRONIC), Vol.11, Iss.1, 2018-01, pp. : 63-70

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Constipation is not associated with dopamine transporter pathology in early drug‐naïve patients with Parkinson's disease

By  

EUROPEAN JOURNAL OF NEUROLOGY, Vol. 25, Iss. 2, 2018-02 ,pp. : 307-312

John Wiley & Sons Inc

Access to resources Recommend Favorite

Parkinson's disease: Neuroimaging and neurophysiology

By  

MOVEMENT DISORDERS, Vol. 30, Iss. S1, 2015-06 ,pp. : S568-S633

John Wiley & Sons Inc

Access to resources Recommend Favorite

Uric acid relates to dopamine transporter availability in Parkinson's disease

By  

ACTA NEUROLOGICA SCANDINAVICA (ELECTRONIC), Vol. 131, Iss. 2, 2015-02 ,pp. : 127-131

John Wiley & Sons Inc

Access to resources Recommend Favorite

New clinical trials for nonmotor manifestations of Parkinson's disease

By  

MOVEMENT DISORDERS, Vol. 30, Iss. 11, 2015-09 ,pp. : 1490-1504

John Wiley & Sons Inc

Access to resources Recommend Favorite

Reduced cerebrospinal fluid mitochondrial DNA is a biomarker for early‐stage Parkinson's disease

By  

ANNALS OF NEUROLOGY, Vol. 78, Iss. 6, 2015-12 ,pp. : 1000-1004

John Wiley & Sons Inc

Access to resources Recommend Favorite